Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding round
CRO
PhaseV reaps $15M in funding to streamline trial design
PhaseV, which uses machine learning to help design clinical trials, received a $15 million funding to expand its offerings and global reach.
Joseph Keenan
Oct 24, 2023 10:55am
Altis Labs reels in $6M in seed funding for AI imaging
Jun 21, 2023 12:30pm
Quris reels in $9M in funding to support innovations in trials
Dec 21, 2022 10:31am
Curavit reaps $5M in series A funding for decentralized trials
Nov 14, 2022 3:35pm
Tessa to use $126M series A to push CAR-Ts through clinic
Jun 9, 2022 8:57am
New report surveys declining biopharma deal activity in Q1
Jun 9, 2022 4:56am